Haitao L. Zhu

Guiyang, 550001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Research on the mechanism of eugenol in the treatment of liver cancer based on network pharmacology, molecular docking technology, and in vitro experiments.

Research on the mechanism of eugenol in the treatment of liver cancer based on network pharmacology, molecular docking technology, and in vitro experiments.

Journal: Anti-cancer drugs
Published: January 09, 2025

A Self-Activating IL-15 Chimeric Cytokine Receptor to Empower Cancer Immunotherapy.

A Self-Activating IL-15 Chimeric Cytokine Receptor to Empower Cancer Immunotherapy.

Journal: ImmunoTargets and therapy
Published: August 07, 2024

Donafenib inhibits PARP1 expression and induces DNA damage, in combination with PARP1 inhibitors promotes apoptosis in liver cancer cells.

Donafenib inhibits PARP1 expression and induces DNA damage, in combination with PARP1 inhibitors promotes apoptosis in liver cancer cells.

Journal: Anti-cancer drugs
Published: June 28, 2024

Chinese guidelines for minimally invasive donor hepatectomy in living donor liver transplantation (2024 edition).

Chinese guidelines for minimally invasive donor hepatectomy in living donor liver transplantation (2024 edition).

Journal: Hepatobiliary surgery and nutrition
Published: June 24, 2024

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.

Journal: Signal transduction and targeted therapy
Published: May 19, 2024

Protective effect of intervention with cannabinoid type-2 receptor agonist JWH133 on pulmonary fibrosis in mice

Protective effect of intervention with cannabinoid type-2 receptor agonist JWH133 on pulmonary fibrosis in mice

Journal: Zhonghua nei ke za zhi
Published: July 03, 2023

LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway.

LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway.

Journal: Medical oncology (Northwood, London, England)
Published: May 03, 2023

E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2.

E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2.

Journal: Medical oncology (Northwood, London, England)
Published: November 30, 2021

Long Noncoding RNA RP5-833A20.1 Suppresses Tumorigenesis In Hepatocellular Carcinoma Through Akt/ERK Pathway By Targeting miR-18a-5p.

Long Noncoding RNA RP5-833A20.1 Suppresses Tumorigenesis In Hepatocellular Carcinoma Through Akt/ERK Pathway By Targeting miR-18a-5p.

Journal: OncoTargets and therapy
Published: June 17, 2019

MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.

MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.

Journal: Molecular and cellular probes
Published: January 27, 2018

Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway.

Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway.

Journal: Oncology reports
Published: May 27, 2017

Bone marrow cells: Important role on neovascularization of hepatocellular carcinoma.

Bone marrow cells: Important role on neovascularization of hepatocellular carcinoma.

Journal: Journal of gastroenterology and hepatology
Published: December 07, 2011
Showing 1-12 of 12

Last Updated: 09/26/2026